$9.34
-0.19 (-1.99%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+113.8% upside
Low Target
$17.96
Average Target
$19.97
High Target
$26.10
Current Price
$9.34
Current
$9.34
$9.34
Target
$19.97
$19.97
$17.96
$19.97 avg
$26.10
Scenario Analysis
Bear Case
$17.96
92.3%
Low target
Base Case
$19.97
+113.8%
Avg target
Bull Case
$26.10
+179.4%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$16.93
-44.8% from high
52-Week Low
$8.48
+10.1% from low
Target vs 52W High
$19.97
+18.0% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.7% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.8% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.6% |
| MRNA | Hold | 31 | 32% | $149.45 | -33.1% |
| REGN | Buy | 36 | 72% | $76.80 | -92.0% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.2% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -33.8% |